Cleared Traditional

Oncospace (K242748) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K242748 · Oncospace, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
211d
Days
Class 2
Risk

K242748 is an FDA 510(k) clearance for the Oncospace. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Oncospace, Inc. (Baltimore, US). The FDA issued a Cleared decision on April 11, 2025 after a review of 211 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oncospace, Inc. devices

Submission Details

510(k) Number K242748 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 12, 2024
Decision Date April 11, 2025
Days to Decision 211 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d slower than avg
Panel avg: 107d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 113
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K242748.
Dose+ (1.0)
K250064 · Mvision AI OY · Sep 2025
RT Elements (4.5)
K250440 · Brainlab AG · Jun 2025
RayCare (2024A SP1)
K242992 · RaySearch Laboratories AB (PUBL) · Apr 2025
RayStation 2023B, RayPlan 2023B, RayStation 2024A, RayPlan 2024A, RayStation 2024A SP3, RayPlan 2024A SP3
K240398 · RaySearch Laboratories AB (PUBL) · Apr 2025
ART-Plan+ (v.3.0.0)
K242822 · Therapanacea Sas · Feb 2025
ARIA Radiation Therapy Management System (18.1)
K242463 · Varian Medical Systems, Inc. · Dec 2024